首页> 外国专利> Biomarkers in blood for diabetic macular edema and uses thereof

Biomarkers in blood for diabetic macular edema and uses thereof

机译:血液中的生物标志物用于糖尿病黄斑水肿和其用途

摘要

In the present invention, amino acids, organic compounds, and oxylipin, which were statistically significantly differentiated from the control group among blood metabolites in type 2 diabetes patients, were selected. Among them, asparagine, aspartic acid, glutamic acid, cysteine, lysine, citric acid and uric acid and oxylipin 12-oxo ETE ( 12-oxo ETE), 15-oxo ETE (15-oxo ETE), 9-oxo ODE (9-oxo ODE) and 20-carboxy leukotriene B4 (20-carboxy leukotriene B4) It was confirmed that the cutoff value of AUC>0.7 The above blood metabolites showed a significant difference between the DME patient group and the non-DME patient group, confirming that it can be used for accurate diagnosis of DME.
机译:在本发明中,选择了氨基酸,有机化合物和氧化肝素,其在2型糖尿病患者中从对照组统计学显着地分化。 其中,天冬酰胺,天冬氨酸,谷氨酸,半胱氨酸,赖氨酸,柠檬酸和尿酸和奥氧哌林12-氧代ete(12-oxo ete),15-oxo ete(15-oxo ete),9-oxo ode(9 - oxo ode)和20-羧基白嘧啶B4(20-羧基白酮B4)证实,AUC> 0.7的截止值上述血液代谢物在DME患者组和非DME患者组之间表现出显着差异,确认 它可用于精确诊断DME。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号